The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD 11,126.0 million in 2024 to an impressive USD 17,780.9 million by 2034. This ...

Patients with end-stage renal disease (ESRD) die in the absence of renal replacement therapy (RRT). In developing countries RRT is not uniformly available and treatment often relies on ...

These early data are reassuring, but there are many questions yet to be explored in the upcoming pivotal trial, Nancy ...

Sangamo (SGMO) reported positive updated data from a Phase 1/2 study of its gene therapy candidate ST-920 in the treatment of Fabry disease. Read more here.

Black and Hispanic patients have increased mortality rates and lower rates of coronary interventions following in-hospital cardiac arrest.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...